Stock Track | Quest Diagnostics Soars 5.09% Intraday on Strong Earnings Beat, Upbeat 2026 Guidance and Enhanced Shareholder Returns

Stock Track

Feb 10

Shares of Quest Diagnostics (DGX) surged 5.09% during intraday trading on Tuesday, following the release of its fourth-quarter and full-year 2025 financial results.

The diagnostic information services provider reported quarterly revenue of $2.81 billion and adjusted earnings per share of $2.42, both exceeding analyst consensus estimates. Furthermore, the company issued 2026 revenue guidance in the range of $11.7 billion to $11.82 billion and adjusted EPS guidance of $10.50 to $10.70, which also topped market expectations, driven by strong demand for laboratory tests.

In tandem with the robust financial performance, Quest Diagnostics announced a 7.5% increase in its quarterly dividend to $0.86 per share, marking 15 consecutive years of dividend growth, and authorized an additional $1 billion for its share repurchase program, significantly boosting shareholder returns.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1189640808"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1189640808\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1189640808?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-10 22:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189640808","market":"us","top_or_hot":-1,"title":"Stock Track | Quest Diagnostics Soars 5.09% Intraday on Strong Earnings Beat, Upbeat 2026 Guidance and Enhanced Shareholder Returns","media":"Stock Track","content":"<p>Shares of Quest Diagnostics (DGX) surged 5.09% during intraday trading on Tuesday, following the release of its fourth-quarter and full-year 2025 financial results.</p><p>The diagnostic information services provider reported quarterly revenue of $2.81 billion and adjusted earnings per share of $2.42, both exceeding analyst consensus estimates. Furthermore, the company issued 2026 revenue guidance in the range of $11.7 billion to $11.82 billion and adjusted EPS guidance of $10.50 to $10.70, which also topped market expectations, driven by strong demand for laboratory tests.</p><p>In tandem with the robust financial performance, Quest Diagnostics announced a 7.5% increase in its quarterly dividend to $0.86 per share, marking 15 consecutive years of dividend growth, and authorized an additional $1 billion for its share repurchase program, significantly boosting shareholder returns.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Quest Diagnostics Soars 5.09% Intraday on Strong Earnings Beat, Upbeat 2026 Guidance and Enhanced Shareholder Returns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Quest Diagnostics Soars 5.09% Intraday on Strong Earnings Beat, Upbeat 2026 Guidance and Enhanced Shareholder Returns\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-10 22:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Quest Diagnostics (DGX) surged 5.09% during intraday trading on Tuesday, following the release of its fourth-quarter and full-year 2025 financial results.</p><p>The diagnostic information services provider reported quarterly revenue of $2.81 billion and adjusted earnings per share of $2.42, both exceeding analyst consensus estimates. Furthermore, the company issued 2026 revenue guidance in the range of $11.7 billion to $11.82 billion and adjusted EPS guidance of $10.50 to $10.70, which also topped market expectations, driven by strong demand for laboratory tests.</p><p>In tandem with the robust financial performance, Quest Diagnostics announced a 7.5% increase in its quarterly dividend to $0.86 per share, marking 15 consecutive years of dividend growth, and authorized an additional $1 billion for its share repurchase program, significantly boosting shareholder returns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DGX","symbol_name":"奎斯特诊疗","start_time":0,"source_url":"","article_id":"1189640808","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189640808","pubTimestamp":1770734397,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Quest Diagnostics (DGX) surged 5.09% during intraday trading on Tuesday, following the release of its fourth-quarter and full-year 2025 financial results.The diagnostic information services...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DGX":"奎斯特诊疗"},"translate_title":"个股追踪|Quest Diagnostics盘中飙升5.09%，因盈利强劲、2026年指引乐观以及股东回报增强","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DGX":1},"content_text":"Shares of Quest Diagnostics (DGX) surged 5.09% during intraday trading on Tuesday, following the release of its fourth-quarter and full-year 2025 financial results.The diagnostic information services provider reported quarterly revenue of $2.81 billion and adjusted earnings per share of $2.42, both exceeding analyst consensus estimates. Furthermore, the company issued 2026 revenue guidance in the range of $11.7 billion to $11.82 billion and adjusted EPS guidance of $10.50 to $10.70, which also topped market expectations, driven by strong demand for laboratory tests.In tandem with the robust financial performance, Quest Diagnostics announced a 7.5% increase in its quarterly dividend to $0.86 per share, marking 15 consecutive years of dividend growth, and authorized an additional $1 billion for its share repurchase program, significantly boosting shareholder returns.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}